Dure pillen doen ons nu allemaal pijn

The pressure on the pharmaceutical industry is now growing not only poor, but also overcoming or inpatient medicines.

The Swiss drug giant Novartis is waving the Colombian government about the price of a cancer drug. It costs $ 15,000 per treatment, unaffordable for many patients in Colombia where the national income averages $ 13,800 per inhabitant (in the Netherlands that is $ 50,000). Colombia wants the price (...)